News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Renowned Fund Manager Says GlaxoSmithKline (GSK)'s Predicaments Are Only Temporary


8/5/2014 6:36:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Veteran fund manager Neil Woodford has revealed that a "long conversation" with GlaxoSmithKline boss Sir Andrew Witty following a recent profits warning inspired confidence in the company.

Mr Woodford's backing will come as a boost to GSK, which saw billions of pounds wiped off its market valuation after it admitted that it would fail to increase its profits this year.

"A long conversation with Glaxo’s chief executive post results has allowed us to maintain confidence in the long term investment case, despite this near term setback," said an update from the renowned investor's new fund, Woodford Equity Income.

Help employers find you! Check out all the jobs and post your resume.

Read at Telegraph


comments powered by Disqus
Telegraph
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES